Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
about
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersCharacterizing autism spectrum disorders by key biochemical pathways.Dysregulation and restoration of translational homeostasis in fragile X syndromeDysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of AutismActivity dependent CAM cleavage and neurotransmissionA delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disordersTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesDysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonismTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackReview of targeted treatments in fragile X syndromeSensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X SyndromeThe Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle.Effects of a social stimulus on gene expression in a mouse model of fragile X syndromeMultifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative DisordersPharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes.Proteolytic regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix metalloproteinase 9 deficient micePersistent astrocyte activation in the fragile X mouse cerebellumExtracellular proteolysis in structural and functional plasticity of mossy fiber synapses in hippocampusMatrix Metalloproteinase-9 Regulates Neuronal Circuit Development and ExcitabilityTwo classes of matrix metalloproteinases reciprocally regulate synaptogenesis.Abnormal intrinsic dynamics of dendritic spines in a fragile X syndrome mouse model in vivoTransient ECM protease activity promotes synaptic plasticity.Potential therapeutic approaches for Angelman syndrome.Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice.miR-132 Regulates Dendritic Spine Structure by Direct Targeting of Matrix Metalloproteinase 9 mRNA.Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1Eco-HAB as a fully automated and ecologically relevant assessment of social impairments in mouse models of autism.Current Perspectives in Autism Spectrum Disorder: From Genes to Therapy.Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activationExtracellular matrix control of dendritic spine and synapse structure and plasticity in adulthood.Treatment of the psychiatric problems associated with fragile X syndrome.Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptomsCell adhesion and invasion mechanisms that guide developing axonsAngelman syndrome: Current and emerging therapies in 2016.
P2860
Q26769948-A253EF5F-861A-41D2-A991-0D83E438520DQ26781645-F0E9F144-83D9-4E27-9FC7-B8B2D5CB2680Q26782616-842D097D-1676-4D6F-8974-588E70BA7883Q26782948-309BD67D-44FD-4B4D-91D8-24079C8277B5Q26796243-99BAF8B7-6E2F-4ADB-9551-F2015FC69BBAQ26797397-F550A3E1-1004-4F3B-B9E6-AE21B292E79BQ27023257-25CF02FB-C315-4819-BACA-7BAA9603DFE9Q27324039-B6E2EF4B-4709-477E-B1A6-4534BF6690EDQ27337360-F5E8867B-AD9C-418F-925B-D22088DA9FDAQ28077180-B50C61AB-61F0-4C93-AFD4-D11C24F068C5Q30354621-B9EC6962-DBE9-4F18-AD58-C4E70F1D1560Q30357779-47A2E37B-DE2B-4373-AD70-4E731325AD81Q33361879-94B52399-CFF6-41F2-A0D8-16456F56682DQ33827442-625EBA95-CC06-4B0A-AF41-4FE040B107C4Q33854483-D85ED994-4C16-474D-AAE8-BE72A17DAD2DQ34959355-854DEFEC-7295-453B-AB95-4A77C84D9C4CQ36097841-5E7DCCE1-C397-43D1-94AB-D47A3F89A3D6Q36186534-C20B857C-9AE6-4B6C-BD37-231FA81A77BDQ36245280-03DDF074-D678-4EAF-846C-8AAE72DF04D5Q36391150-0DB2F691-453F-462A-977C-6DF936CD0F3EQ36497245-49681BBC-E23B-49FA-8293-9FBC510A5F9BQ36933910-90FF4FE7-1B5B-468F-8A63-0A52A8154BF0Q36990679-E4006E52-F69D-4C90-BB57-6E69B1275E6EQ36992786-83BD9CC4-4AAF-4E0E-9FCE-C0355ECB5677Q37006293-BBF78561-C8D6-403D-ABAD-FC9E9FE2FC8AQ37136673-44CC074A-FF41-4B6B-8EB2-06A22F0DC1BCQ37299355-528629A3-F3FF-42D5-AB10-5C3092F2F15DQ37352763-89A0DECE-1558-4C5B-8293-42D439B84685Q37388683-C4A74CA7-EEE6-4FBC-9EC5-166812196C30Q37444926-1329E590-1795-4E91-89AE-A537362777CFQ37688952-0F60F3A1-8786-4D84-BBB6-1B2D425356C9Q37708436-2FCC27A3-E0D5-45D9-9582-243FFC7799E6Q38264895-2638C05D-5EC0-430E-AA00-295FAF25A720Q38324675-18B36083-6262-4E70-9643-85F171B99957Q38402659-94A7C416-BB27-41CB-BD20-F8A77C49CEA0Q38622769-553FF3CE-0CC8-4530-9288-289A4DCCA997Q38678066-4D23638F-6793-4891-AD3F-411BAA2C00EEQ38721750-C9A8CCF4-76EF-4F0F-8731-3AA2577980BFQ38822898-1376E696-9C48-4275-BF41-1C884FD1A7BBQ39012491-7D869D77-E686-44C8-B12C-1DFA383F1436
P2860
Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@ast
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@en
type
label
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@ast
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@en
prefLabel
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@ast
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@en
P2093
P2860
P1476
Genetic removal of matrix meta ...... e X syndrome in a mouse model.
@en
P2093
Douglas W Ethell
Iryna M Ethell
Lorraine E Dansie
Peter W Hickmott
P2860
P304
P356
10.1523/JNEUROSCI.1162-14.2014
P407
P577
2014-07-01T00:00:00Z